Geriatric Considerations in Colorectal Surgery

Dedicated deep-dive on the geriatric colorectal surgery population, complementing (not duplicating) the elderly/frailty content already on Preoperative Evaluation & Perioperative Risk Optimization (sourced from the general perioperative-medicine ASCRS Ch. 6) and the "Elderly patients" subsection of Enhanced Recovery After Surgery (ERAS) (ASCRS Ch. 7). This chapter is written by geriatric-surgery specialists and goes substantially further: additional frailty-screening instruments, a full functional-recovery/patient-reported-outcomes framework, and — uniquely — an interdisciplinary expert-consensus algorithm for personalizing rectal cancer treatment specifically in geriatric patients. Most colorectal cancer occurs in patients >65, and life expectancy in this population is higher, at any given age, than commonly assumed — making "geriatric" assessment central to modern colorectal practice rather than a niche subspecialty concern.

Frailty screening

Comprehensive geriatric assessment (CGA) remains the gold standard (see Preoperative Evaluation & Perioperative Risk Optimization for CGA's domains and the Hopkins Frailty Score/mFI/RAI instruments already covered there). This chapter catalogs additional screening tools in a comparative table, several of which are novel additions to this wiki:

ECOG Performance Status — 0-5 scale, widely used in oncology to gauge a patient's ability to tolerate treatment.
ADLs (Activities of Daily Living, Katz) — bathing, dressing, toileting, transferring, continence, feeding; functional-independence screen.
Mini-Cog — 3-item recall + clock-drawing test; rapid cognitive screen (also covered on the Preoperative Evaluation page).
fTRST (Flemish Triage Risk Screening Tool) — validated specifically for use in the emergency department setting to predict outcomes in older adults undergoing emergency general surgery (Zattoni et al.) — a distinct use-case from the elective-setting tools emphasized elsewhere in this wiki.
TUG (Timed Up and Go) — functional mobility test; the PREOP study found TUG outperformed ASA classification alone for predicting major postoperative complications.
G8 — an oncology-specific geriatric screening tool.
NRS (Nutritional Risk Screening).
ASA classification and CACI (Cumulative Illness Rating Scale) — general comorbidity/risk indices, included for comparison rather than as geriatric-specific tools.

Domains of geriatric assessment

Functional assessment: TUG test plus ADL questioning; TUG-vs-ASA-score comparison (PREOP study) found TUG a better predictor of major complications.
Cognitive function: Mini-Cog.
Polypharmacy: explicit assessment domain, reflecting the compounding risk of multiple medications/interactions in geriatric surgical patients.
Nutritional assessment: overlaps with malnutrition content on Preoperative Evaluation & Perioperative Risk Optimization.
Social support and patient's wishes/goals of care: explicitly named domains — the chapter emphasizes early identification of patient goals as central to geriatric surgical decision-making, not an afterthought.

Prehabilitation

Multidimensional programs (medical, physical/exercise, nutritional, psychological) — see Preoperative Evaluation & Perioperative Risk Optimization for the general prehabilitation evidence base (including the "genuinely mixed" outcomes synthesis already documented there). This chapter adds:

Minnella et al.: patients with poor baseline walking capacity benefit most from multimodal prehabilitation — i.e., the patients who look least fit to begin with may have the most to gain.
A related finding that ~30% of patients do not respond to prehabilitation at all — an important caveat against assuming universal benefit.
Gillis et al.: systematic review supporting nutritional prehabilitation specifically.
Carli et al.: prehabilitation response can be used to guide the choice of neoadjuvant treatment window/timing, "finally utilizing frailty screening data" rather than treating frailty assessment and prehabilitation as separate exercises.

Surgical considerations

Enhanced recovery pathway: elements apply to geriatric patients as they do generally — see Enhanced Recovery After Surgery (ERAS) for the full pathway; this chapter reinforces that ERAS is safe and beneficial (shorter length of stay, fewer complications) in patients >65-70, consistent with that page's existing "Elderly patients" subsection.
Minimally invasive surgery: appropriate in geriatric patients when technically feasible; laparoscopic/robotic approaches are not contraindicated by age alone.
Emergency surgery: emergency general surgery outcomes are worse in geriatric patients overall; the fTRST has validated use specifically in the emergency department to risk-stratify these patients (Zattoni et al.).
Avoiding age-based bias: the chapter is explicit that surgeons should not default to "palliative" or lesser operations based on chronological age alone when cure is achievable — frailty, not age, should drive the decision between curative-intent and palliative approaches. This principle directly parallels and reinforces the Personalized Treatment of Rectal Cancer task force's core message below ("frailty and not chronological age should be used in risk stratification").

Postoperative management

Geriatric comanagement: Shahrokni et al. compared 1,009 comanaged vs. 846 non-comanaged patients and found improved mortality outcomes with routine geriatrician/surgeon comanagement after cancer surgery.
Delirium: risk factors and prevention overlap with (but add to) the delirium content already on Preoperative Evaluation & Perioperative Risk Optimization. A cited systematic review/ meta-analysis found multifactorial nonpharmacologic delirium-prevention interventions reduced delirium incidence with OR 0.47 — a specific effect-size figure not previously captured on this wiki.
Rehabilitation: targeted postoperatively to prevent functional decline, consistent with the broader geriatric-surgery goal of preserving independence, not just survival.

Functional recovery and patient-reported outcomes

GOSAFE study (Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery, 977 patients, with a 440-patient colorectal-specific subgroup analysis): correlates Clavien-Dindo complication severity with functional decline, reinforcing that complication grade alone under-captures what matters most to geriatric patients.
ICHOM domains (International Consortium for Health Outcomes Measurement): patient-reported outcome measures for colorectal cancer (EORTC-QLQ C30/CR29, MSKCC bowel function dietary subscale) and for older persons generally (SF-36, UCLA 3-item loneliness/social-functioning scale) share substantial overlap in domains assessed (fatigue, physical function/ADLs, sexual and bowel functioning, mood, pain) — the chapter proposes combining both measure sets, plus clinical assessment of polypharmacy and participation in decision-making, as a comprehensive PROM package for older colorectal cancer patients specifically (Doolin et al.).
Organ-specific recovery: bowel, bladder, and sexual function are explicitly named as posttreatment endpoints requiring attention — see Low Anterior Resection Syndrome (LARS) and Sexual Function After Colorectal Surgery for the dedicated pages on these topics. The LARS score and Cleveland Clinic Fecal Incontinence Score are named as validated instruments appropriate for use in this population.
Colostomy vs. coloanal anastomosis decision-making: for geriatric patients with poor baseline sphincter tone, a permanent colostomy may be functionally preferable to a coloanal anastomosis that would leave the patient with poor continence — an explicit, nuanced recommendation against reflexively pursuing sphincter preservation in this population. This directly extends Low Anterior Resection Syndrome (LARS)'s existing content on the sphincter-preservation-vs- quality-of-life tradeoff, adding an age/frailty-specific decision lens.

Personalized treatment of rectal cancer in geriatric patients

A 29-member interdisciplinary task force (European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and the American College of Surgeons Commission on Cancer) produced expert consensus recommendations specifically for managing rectal cancer in geriatric patients (Montroni et al.):

General principles: treatment decisions should weigh physiological age (not chronological age), life expectancy, risks/benefits of treatment vs. nontreatment, treatment tolerance, patient goals/ wishes, and possible treatment barriers.
Multidisciplinary team: frailty (not chronological age) drives risk stratification. Mandatory frailty screening (e.g., G8, Mini-Cog, TUG, history of falls); frail patients should have a geriatrician routinely involved in the MDT; fit patients should be treated per algorithms developed for younger patients.
Patient optimization: multidimensional prehabilitation (exercise, nutrition, anxiety/depression treatment) should be used pretreatment, with particular attention to the window available before neoadjuvant chemoradiation.
Surgical treatment: TME via open/laparoscopic/robotic/transanal (taTME) approaches is not contraindicated by age alone. Laparoscopy is preferred by experienced surgeons (safe and effective in the elderly); robotic approaches are acceptable per surgeon preference but not shown superior to laparoscopy and cost more; taTME is advised by expert surgeons for its lower conversion rate, though long-term data are lacking (see Total Mesorectal Excision (TME) & Sphincter-Sparing Resection). Local excision requires balancing oncologic outcomes against goals of care/frailty, and is not recommended after radiation therapy given increased morbidity (see Local Excision of Rectal Neoplasms). Surgical emergencies (bleeding, obstruction, perforation) should be preempted and treated early when they occur.
Treatment of locally advanced disease: neoadjuvant chemoradiotherapy can increase local control but risks toxicity that could prevent potentially curative surgery; capecitabine is contraindicated in renal failure. Contact X-ray brachytherapy is available at select centers as an EBRT adjunct for small residual tumors (<3cm) or as monotherapy for early (cT1) rectal cancer <3cm. Watch and wait should be considered in patients achieving complete clinical response, but requires experienced multidisciplinary expertise (no single reliable predictor of complete response exists, though tumor size/shrinkage rate are useful prognosticators) and must incorporate patient goals/ wishes. Adjuvant chemotherapy after neoadjuvant chemoradiation and surgery is not advised in geriatric patients — an explicit, actionable recommendation.
Treatment of synchronous liver metastases: liver surgery should only be performed with curative intent; neoadjuvant chemotherapy (and radiation, if indicated) is suggested when the primary tumor is asymptomatic; synchronous resections should be avoided in this population.
Outcomes: enhanced recovery pathways reduce length of stay and complications in elderly patients (see Enhanced Recovery After Surgery (ERAS)); key elements are early IV fluid discontinuation, early oral intake, timely urinary catheter removal (pelvic dissection permitting), early mobilization, limited opioids, and minimally invasive surgery, with patient/caregiver engagement crucial for compliance. Functional recovery should be a pivotal posttreatment endpoint — specifically, the morbidity of a "permanent" diverting loop ileostomy should be weighed, favoring colostomy over diversion in patients unlikely to undergo reversal. PROMs should be recorded as a primary (not secondary) outcome by the clinical team. Healthcare cost recommendations favor a shift toward value-based care, with early diagnosis and frailty assessment as cost-containment tools.
Treatment algorithm (Fig. 67.3): stratifies patients ≥80 years old by fit vs. frail/vulnerable status. Fit patients with complete clinical response can be offered watch-and-wait or standard curative-intent treatment with an enhanced recovery pathway; frail/vulnerable patients receive adapted care with geriatrician-inclusive MDT staging, local excision +/- radiotherapy, or nonsurgical/watch-and-wait management depending on response and patient perspective — always with prehabilitation considered where surgery proceeds.
Life expectancy data (Fig. 67.4): historical data associated TME with increased mortality in the elderly and discouraged surgery on that basis; modern surgical/perioperative data show that properly selected elderly patients undergoing rectal cancer surgery today have a life expectancy similar to peers without rectal cancer — reflecting improved frailty assessment, fitness optimization, minimally invasive technique, and perioperative care rather than any change in tumor biology. This reframes the historical age-based reluctance to operate as outdated rather than cautious.

Conclusions (chapter's own framing)

Geriatric colorectal patients require multimodality, multispecialty intervention. Patient goals and wishes should be identified and addressed early. All patients should undergo office-based frailty screening with geriatric-specialist referral if frail; frailty should be optimized via multimodality prehabilitation. Standard perioperative principles (minimally invasive surgery, enhanced recovery) apply to geriatric patients as to others. Geriatric comanagement improves postoperative outcomes and helps identify/treat geriatric syndromes like delirium early. Functional recovery and patient-reported outcomes are as important as cancer-related outcomes in this population and should be measured and discussed with patients preoperatively — the explicit aim being to avoid both undertreatment based on age and overtreatment based on frailty.

Preoperative Evaluation & Perioperative Risk Optimization — general perioperative risk assessment/frailty content (CGA, Hopkins Frailty Score, mFI, RAI, Mini-Cog, delirium risk factors); this page adds geriatric-oncology-specific screening tools (fTRST, G8, TUG-vs-ASA comparison detail) and functional-recovery/PROM content not covered there.
Enhanced Recovery After Surgery (ERAS) — its existing "Elderly patients" subsection is reinforced and extended here with the rectal-cancer-specific ERAS outcomes recommendations from the interdisciplinary task force.
Rectal Cancer — this page's Personalized Treatment of Rectal Cancer section is the geriatric-specific treatment-decision layer on top of that page's general rectal cancer content.
Total Mesorectal Excision (TME) & Sphincter-Sparing Resection — TME approach selection (open/laparoscopic/robotic/taTME) in geriatric patients per the task force recommendations.
Local Excision of Rectal Neoplasms — task force guidance against local excision after radiation therapy in geriatric patients.
Total Neoadjuvant Therapy (TNT) — neoadjuvant chemoradiation timing/toxicity tradeoffs in geriatric patients.
Low Anterior Resection Syndrome (LARS) — LARS score as a validated PROM instrument in this population, plus the colostomy-vs-coloanal-anastomosis decision-making extension for patients with poor baseline sphincter tone.
Sexual Function After Colorectal Surgery — organ-specific (sexual) functional recovery named as a posttreatment endpoint in geriatric patients.
General Postoperative Complications — delirium content here (OR 0.47 for multifactorial prevention) adds a specific effect size to that page's existing delirium risk-factor discussion.
Pediatric Colorectal Disorders — the wiki's other age-extreme population chapter; both emphasize that age alone is a poor surrogate for individualized risk/decision-making, from opposite ends of the age spectrum.

Open items / gaps

No primary literature yet independently ingested for the GOSAFE study, the interdisciplinary task force's full recommendations (Montroni et al.), or the individual frailty-screening-tool validation studies (fTRST/Zattoni, PREOP/TUG) — presented here as the chapter's own synthesis.
The ~30% prehabilitation non-responder figure (Minnella et al.) is not yet reconciled against the "genuinely mixed" aggregate prehabilitation evidence already flagged on Preoperative Evaluation & Perioperative Risk Optimization — both point the same direction (response is heterogeneous) but come from different studies; flagged rather than merged. Adjuvant chemotherapy after neoadjuvant chemoradiation and surgery is not advised in geriatric patients per this chapter — worth flagging as a potential point of tension if a future chemotherapy-focused chapter (e.g., on adjuvant therapy for rectal cancer generally) is ingested and presents a less age-stratified recommendation.

Colorectal LLM Wiki